DAPK1 and lung carcinoma: Finally, it was shown that treatment with decitabine (5‐aza‐2′‐deoxycytidine, DAC) inhibits the DNA methylation of the DAPK1 promoter and restores DAPK1 expression in lung cancer cell lines (Tang et al, 2004).